Loading company…
Reus, Spain-based CreatSens Health company making a blood-drop kidney test for chronic kidney disease monitoring.
Founded in 2017 and headquartered in Reus, Spain, CreatSens Health S.L. develops Renalyse, a cloud-based device for chronic kidney disease monitoring and diagnostics. Its test assesses key kidney function indicators from a single drop of blood, for primary care centers, hospitals and individual patients. In 2023, it reported revenue of EUR 478,334.20. On October 9, 2023, it raised EUR 1.00 mn led by Fundación Botín, with Genesis Biomed also investing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in